Head-to-head · Cost-Efficiency Index
Alan Meds vs No BS RX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Alan Meds
Budget-first shoppers who want the lowest sema price plus an oral route nationwide.
Visit Alan MedsNo BS RX
Someone who wants every term and every dose level comparable without starting an intake to see a price.
Visit No BS RXThe verdict
Alan Meds takes it, leading the Cost-Efficiency Index 84 to 82. Rock-bottom $99 semaglutide with an oral option and all-50 access — strong on price, but not LegitScript-verified. No BS RX still earns a B− — Someone who wants every term and every dose level comparable without starting an intake to see a price.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Alan Meds.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Alan Meds | No BS RX |
|---|---|---|
| Cost-Efficiency Index | 84/100 | 82/100 |
| Semaglutide / mo | $99/mo | $179/mo month-to-month; a separate low-dose program runs $140 |
| Tirzepatide / mo | $145/mo | $249/mo month-to-month; a separate low-dose program runs $140 |
| Semaglutide / yr (modeled) | $1,188 | $2,148 |
| Tirzepatide / yr (modeled) | $1,740 | $2,988 |
| Coverage | All 50 states | Not disclosed |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #21 | #28 |
Alan Meds
84/100Where the value is
- $99 semaglutide and $145 tirzepatide — among the cheapest disclosed in the ranking
- Nationwide all-50 access with an oral/sublingual option
- Both molecules published for straightforward cost modeling
The tradeoffs
- Not LegitScript-certified — oversight harder to verify
- Compounded only — no brand-name access
Regulatory note: the FDA issued a warning letter to Alan Health Technologies Inc. dba Alan in February 2026. We still list and link to Alan Meds; you should know the letter is on the public record before you decide.
No BS RX
82/100Where the value is
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
The tradeoffs
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.